Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.

@article{McCammon2009ToxicityAO,
  title={Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.},
  author={Robert McCammon and Kyle E Rusthoven and Brian Kavanagh and Sherri Newell and Francis Newman and David Raben},
  journal={International journal of radiation oncology, biology, physics},
  year={2009},
  volume={75 2},
  pages={413-20}
}
PURPOSE To evaluate the toxicity of pelvic intensity-modulated radiotherapy (IMRT) with hypofractionated simultaneous integrated boost (SIB) to the prostate for patients with intermediate- to high-risk prostate cancer. METHODS AND MATERIALS A retrospective toxicity analysis was performed in 30 consecutive patients treated definitively with pelvic SIB-IMRT, all of whom also received androgen suppression. The IMRT plans were designed to deliver 70 Gy in 28 fractions (2.5 Gy/fraction) to the… CONTINUE READING
22 Citations
39 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 39 references

The impact of short course pre-operative radiotherapy on patients’ quality of life: Data from the MRC CR07/NCIC CO16 randomised clinical trial in patients with rectal cancer

  • D Sebag-Montfiore, P Quirke, R Steele
  • Int J Radiat Oncol Biol Phys 2008;72:S61
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…